Cellnovo Limited acquired commercial license for Artificial Pancreas technology from TypeZero Technologies LLC.

Commercial License For Artificial Pancreas Technology of TypeZero Technologies LLC comprises Artificial Pancreas (AP) software that monitors blood glucose levels via a smartphone application.